Table 3 Complication and Treatment during hospitalizationin the Discharged and Death Groups
Total(n = 141) | Discharged(n = 123) | Death(n = 18) | Ρ value | |
|---|---|---|---|---|
Complication-no.(%) | ||||
Arrhythmia | 39(27.7) | 32(26.0) | 7(38.9) | 0.391 |
ARDS | 17(12.1) | 7(5.7) | 10(55.6) | 0.000 |
Shock | 8(5.7) | 0(0) | 8(44.4) | 0.000 |
Treatment-no.(%) | ||||
Antiviral therapy | 131(92.9) | 116(92.8) | 15(93.8) | 1.000 |
Oseltamivir | 18(12.8) | 17(13.8) | 1(5.6) | 0.546 |
Arbidol | 129(91.5) | 113(91.9) | 16(88.9) | 1.000 |
Oseltamivir+Arbidol | 16(11.3) | 15(12.2) | 1(5.6) | 0.666 |
Antibiotics | 108(76.6) | 90(73.2) | 18(100.0) | 0.027 |
Antifungal | 6(4.3) | 3(2.4) | 3(16.7) | 0.028 |
Glucocorticoid | 29(20.6) | 16(13.0) | 13(72.2) | 0.000 |
Immunoglobulin transfusion | 15(10.6) | 8(6.5) | 7(38.9) | 0.000 |
Blood transfusion | 8(5.7) | 5(4.1) | 3(16.7) | 0.107 |
NIV-no.(%) | 15(10.6) | 4(3.3) | 11(61.1) | 0.000 |
IMV-no.(%) | 6(4.3) | 1(0.8) | 5(27.8) | 0.000 |